Aoris Investment Management, in its Q2 2026 investor letter, stated it sold its position in Accenture (ACN) late in the quarter. The fund noted the investment negatively impacted its annual portfolio returns by 5.2%, attributing the misjudgment to an assumption that Accenture's underlying revenue growth would return to its historical 6-7% rate, which has instead been stuck at 1-4% since 2024.